These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation. De Ruvo N, Cucchetti A, Lauro A, Masetti M, Cautero N, Di Benedetto F, Dazzi A, Del Gaudio M, Ravaioli M, Zanello M, La Barba G, di Francesco F, Risaliti A, Ramacciato G, Pinna AD. Transplant Proc; 2005; 37(6):2607-8. PubMed ID: 16182760 [Abstract] [Full Text] [Related]
3. Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation. De Ruvo N, Cucchetti A, Lauro A, Masetti M, Di Benedetto F, Cautero N, La Barba G, Dazzi A, Di Francesco F, Molteni G, Romano A, Ramacciato G, Risaliti A, Pinna AD. Clin Transplant; 2005 Apr; 19(2):255-8. PubMed ID: 15740564 [Abstract] [Full Text] [Related]
5. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE. J Thorac Cardiovasc Surg; 2005 Aug; 130(2):528-37. PubMed ID: 16077423 [Abstract] [Full Text] [Related]
6. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK. Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143 [Abstract] [Full Text] [Related]
10. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database. Watt KD, Dierkhising R, Heimbach JK, Charlton MR. Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474 [Abstract] [Full Text] [Related]
13. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Tan HP, Kaczorowski D, Basu A, McCauley J, Marcos A, Donaldson J, Unruh M, Randhawa P, Zeevi A, Shapiro R. Transplant Proc; 2005 Dec; 37(10):4235-40. PubMed ID: 16387087 [Abstract] [Full Text] [Related]
14. Use of antilymphocyte induction therapy in liver transplantation. Wall WJ. Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019 [Abstract] [Full Text] [Related]
18. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience. Lee H, Lee S, Jeon JS, Kwon SH, Noh H, Han DC, Yun S, Song D. Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348 [Abstract] [Full Text] [Related]
19. Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection. Nair S, Loss GE, Cohen AJ, Eason JD. Transplantation; 2006 Feb 27; 81(4):620-2. PubMed ID: 16495812 [Abstract] [Full Text] [Related]